|
Japan PharmaCyclopedic is the most complete source of
information on Japanese pharmaceutical companies and their products in the
world. Information includes company history and summary, operating results and
forecast, business breakdown, major shareholders, top executives, employees,
R&D pipeline, and leading marketed products.
The Japan PharmaCyclopedic is designed to serve the needs of
pharmaceutical executives in the fields of licensing, international operations,
mergers and acquisitions, strategic planning, and marketing. The publication is
researched and written by Tatsuo Arita, RPh, a former senior Japanese executive
who resides in Japan. Mr. Arita has over 40 years of experience in the
pharmaceutical industry, having had a career focus in licensing, market
research and international operations. (Cole & Associates with Mr. Arita
has edited the Japan PharmaCyclopedic for over 10 years.)
Information presented within the Japan PharmaCyclopedic has
been developed from multiple Japanese language sources, including
non-circulated biannual and annual data required of the industry by the
Japanese government. The 2005/06 edition of the Japan PharmaCyclopedic
includes the latest information on 70 established and new Japanese
pharmaceutical manufacturers and their products.
The Japan PharmaCyclopedic 2005/06 edition also includes a
listing of the top 120 pharmaceutical companies in Japan, ranked by sales, with
the 130 leading products ranked by domestic sales; the top 25 exported
products; top wholesalers information; and with key mergers occurring, the
extremely useful latest information on the merged companies. Available in a
paper edition and on a searchable CD-ROM (new).
New Features in 2005/06
. Searchable CD ROM
. A special report on the Korosho Vision Statement and World Markets
. Japanese Mergers-Review of the five most recent merges
. In-Depth Review R&D Pipelines & Priorities of the Top 50 Companies
. Custom Reports on Request Other New Features
. 10 New Companies profiled
. Review of the New Drug Approval Process and the function of Kiko
. New Drugs and Line Extensions Approved by Year since 1993
. NHI Pricing Formula & Process (how drugs are priced in Japan)
. Number of Generic Product Approvals
To demonstrate the reach and scope of the 2005/06 Japan PharmaCyclopedic
Edition, this website (www.coleconsult.com) contains:
. The Table of Contents - Volume I and II
. Sample Company Profile - The featured company is Taiho Pharmaceutical Co.,
the leading oncology company in Japan.
|
